Beijing Science Sun Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio
Beijing Science Sun Pharmaceutical Co Ltd cash flow-to-debt ratio. Beijing Science Sun Pharmaceutical Co Ltd (300485) has a Cash Flow-to-Debt Ratio of 0.17x as of September 2025, meaning its operating cash flow of CN¥28.68 Million could theoretically repay 0% of its total liabilities (CN¥171.26 Million) in one year. Check how high is Beijing Science Sun Pharmaceutical Co Lt's earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Beijing Science Sun Pharmaceutical Co Ltd (2011–2025)
Cash flow-to-debt ratio of Beijing Science Sun Pharmaceutical Co Ltd from 2011 to 2025. Historical debt coverage capacity for Beijing Science Sun Pharmaceutical Co Ltd across 15 annual periods. Check cash flow reinvestment rate of Beijing Science Sun Pharmaceutical Co Lt to assess the company's total reinvestment commitment from operating cash flow.
Beijing Science Sun Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (2011–2025)
Beijing Science Sun Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 2011 to 2025. Year-by-year debt coverage analysis for Beijing Science Sun Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Beijing Science Sun Pharmaceutical Co Lt cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.15x | CN¥27.08 Million | CN¥175.95 Million | ▼ -81.2% |
| 2024 | 0.82x | CN¥135.97 Million | CN¥166.48 Million | ▲ +495.3% |
| 2023 | 0.14x | CN¥21.21 Million | CN¥154.61 Million | ▼ -80.5% |
| 2022 | 0.70x | CN¥110.43 Million | CN¥157.10 Million | ▼ -54.5% |
| 2021 | 1.55x | CN¥183.30 Million | CN¥118.54 Million | ▼ -17.3% |
| 2020 | 1.87x | CN¥263.73 Million | CN¥141.13 Million | ▲ +2.1% |
| 2019 | 1.83x | CN¥172.52 Million | CN¥94.26 Million | ▲ +156.2% |
| 2018 | 0.71x | CN¥146.52 Million | CN¥205.07 Million | ▼ -11.6% |
| 2017 | 0.81x | CN¥108.21 Million | CN¥133.91 Million | ▼ -55.0% |
| 2016 | 1.79x | CN¥212.89 Million | CN¥118.63 Million | ▼ -34.3% |
| 2015 | 2.73x | CN¥169.36 Million | CN¥62.00 Million | ▼ -8.6% |
| 2014 | 2.99x | CN¥214.23 Million | CN¥71.71 Million | ▼ -28.2% |
| 2013 | 4.16x | CN¥196.82 Million | CN¥47.33 Million | ▼ -3.7% |
| 2012 | 4.32x | CN¥151.93 Million | CN¥35.18 Million | ▲ +81.6% |
| 2011 | 2.38x | CN¥77.06 Million | CN¥32.39 Million | — |